Sanford C. Bernstein Increases agilon health (NYSE:AGL) Price Target to $3.15

agilon health (NYSE:AGL - Get Free Report) had its price objective upped by Sanford C. Bernstein from $2.50 to $3.15 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a "market perform" rating on the stock. Sanford C. Bernstein's price objective points to a potential upside of 11.31% from the company's previous close.

Other analysts also recently issued research reports about the stock. William Blair downgraded shares of agilon health from an "outperform" rating to a "market perform" rating in a report on Friday, November 8th. TD Cowen reduced their target price on agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a research report on Monday, November 11th. Needham & Company LLC assumed coverage on agilon health in a research note on Friday, January 10th. They issued a "hold" rating on the stock. Bank of America downgraded agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective for the company. in a research report on Wednesday, October 2nd. Finally, Evercore ISI decreased their target price on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a research report on Tuesday, October 8th. Two investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $4.03.

agilon health Trading Up 2.9 %

NYSE AGL traded up $0.08 on Wednesday, reaching $2.83. 5,407,538 shares of the company were exchanged, compared to its average volume of 4,618,648. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The business's fifty day moving average price is $2.07 and its 200 day moving average price is $3.68. The stock has a market capitalization of $1.17 billion, a P/E ratio of -3.01 and a beta of 0.53. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period in the previous year, the firm posted ($0.06) EPS. Analysts forecast that agilon health will post -0.52 earnings per share for the current year.

Insider Transactions at agilon health

In related news, Director John William Wulf acquired 45,000 shares of the stock in a transaction dated Thursday, December 5th. The stock was acquired at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares in the company, valued at $449,369.94. This represents a 27.93 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Karen Mcloughlin bought 25,000 shares of agilon health stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now owns 73,166 shares of the company's stock, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 90,000 shares of company stock valued at $198,100. 3.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On agilon health

Several institutional investors have recently modified their holdings of AGL. Oak Thistle LLC acquired a new stake in agilon health in the fourth quarter valued at $25,000. Pines Wealth Management LLC purchased a new position in shares of agilon health in the 4th quarter valued at about $51,000. JPMorgan Chase & Co. raised its position in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock worth $5,563,000 after acquiring an additional 1,083,492 shares in the last quarter. Virtu Financial LLC purchased a new stake in agilon health during the third quarter worth approximately $120,000. Finally, Geode Capital Management LLC boosted its holdings in agilon health by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company's stock valued at $27,097,000 after purchasing an additional 84,889 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.